Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Adults With Type 2 Diabetes

Sponsor
University Ghent (Other)
Overall Status
Completed
CT.gov ID
NCT03291171
Collaborator
(none)
56
1
2
16.5
3.4

Study Details

Study Description

Brief Summary

The aim of this study is to investigate whether and how 'MyPlan 2.0' helps adults with type 2 diabetes to be more physically active or less sedentary. Two groups will be created, an intervention group and a waiting-list control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MyPlan 2.0
N/A

Detailed Description

The aim of this study is to investigate whether and how 'MyPlan 2.0' helps adults with type 2 diabetes to be more physically active or less sedentary. Two groups will be created, an intervention group and a waiting-list control group. Both groups will be tested during three testing waves: pretest, posttest and follow-up test. Only the intervention group will be given acces to 'MyPlan 2.0'. 'MyPlan 2.0' consists of a website and mobile application targeting physical activity and sedentary behaviour. The intervention has a duration of five weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
56 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized controlled trial with two groups: intervention group and waiting-list control groupRandomized controlled trial with two groups: intervention group and waiting-list control group
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Controlled Trial to Identify the Effect and the Working Mechanisms of MyPlan 2.0, a Self-regulation-based e- and mHealth Intervention Targeting Physical Activity and Sedentary Behaviour, in Adults With Type 2 Diabetes.
Actual Study Start Date :
Oct 15, 2017
Actual Primary Completion Date :
Mar 1, 2019
Actual Study Completion Date :
Mar 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

Participants will receive the e- and mHealth intervention 'MyPlan 2.0'.

Behavioral: MyPlan 2.0
MyPlan 2.0 consists of five sessions. During these five sessions the following behaviour change techniques are used to motivate users to be more physically active or to sit less: exploring risk perceptions and perceived benefits, exploring social support, providing feedback, action planning, coping planning and monitoring.

No Intervention: Waiting-list control group

Participants will not receive the e- and mHealth intervention 'MyPlan 2.0', but will be given access to the intervention after all testing phases.

Outcome Measures

Primary Outcome Measures

  1. Change in objective total, light and moderate-to-vigorous physical activity (PA) [Pretest, posttest (6 weeks) and follow-up (6 months)]

    Change in amount of total, light and moderate-to-vigorous physical activity, measured via accelerometers

  2. Change in objective sedentary behaviour [Pretest, posttest (6 weeks) and follow-up (6 months)]

    Change in amount of total sitting time, measured via accelerometers

  3. Change in self-reported total, light and moderate-to-vigorous physical activity (PA) [Pretest, posttest (6 weeks) and follow-up (6 months)]

    Change in amount of total, light and moderate-to-vigorous physical activity, measured via the International Physical Activity Questionnaire (IPAQ)

  4. Change in self-reported sedentary behaviour [Pretest, posttest (6 weeks) and follow-up (6 months)]

    Change in amount of total sitting time, measured via the LASA sedentary behaviour self-report questionnaire

Secondary Outcome Measures

  1. Change in self-efficacy [Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)]

    Change in amount of self-efficacy to change behaviour, measured via 3 validated items (questionnaire)

  2. Change in outcome expectancies [Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)]

    Outcome expectancies regarding the behaviour change, measured via 3 validated items (questionnaire)

  3. Change in risk perception [Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)]

    Risk perception about the behaviour, measured via 3 validated items (questionnaire)

  4. Change in intention [Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)]

    Amount of intention to change the behaviour, measured via 3 validated items (questionnaire)

  5. change in action planning [Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)]

    Amount of action planning for behaviour change, measured via 3 validated items (questionnaire)

  6. change in coping planning [Pretest, after week 1, after week 2, after week 3, after week 4, posttest (6 weeks), and follow-up (6 months)]

    Amount of coping planning for behaviour change, measured via 3 validated items (questionnaire)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 18 years or older

  • Type 2 diabetes

  • Have access to internet

  • Being computer literate

Exclusion Criteria:
  • not Dutch Speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Movement and Sports Sciences Ghent Belgium 9000

Sponsors and Collaborators

  • University Ghent

Investigators

  • Principal Investigator: Ilse De Bourdeaudhuij, Professor, University Ghent
  • Principal Investigator: Geert Crombez, Professor, University Ghent
  • Principal Investigator: Maïté Verloigne, PostDoc, University Ghent

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Ghent
ClinicalTrials.gov Identifier:
NCT03291171
Other Study ID Numbers:
  • MyPlan2.0_diabetes
First Posted:
Sep 25, 2017
Last Update Posted:
Dec 6, 2021
Last Verified:
Dec 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Ghent
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 6, 2021